Detalles de la búsqueda
1.
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma.
J Transl Med
; 19(1): 232, 2021 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34059094
2.
Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art.
Pharmacogenomics J
; 19(1): 5-14, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190521
3.
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
Acta Oncol
; 62(12): 1979-1982, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934081
4.
Prospectively scored pulmonary toxicities in non-small cell lung cancer: Results from a randomized phase II dose escalation trial.
Clin Transl Radiat Oncol
; 27: 8-14, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33385069
5.
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
Radiat Oncol
; 16(1): 131, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266462
6.
Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 12(4)2020 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32290439
7.
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients.
Lung Cancer
; 143: 67-72, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32213382
8.
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer.
Lung Cancer
; 141: 37-43, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31945708
9.
A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC.
Radiother Oncol
; 123(2): 276-281, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28410809
10.
Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy.
Radiother Oncol
; 118(3): 465-70, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26803187
11.
Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation.
BMJ Case Rep
; 20142014 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25056302
12.
EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.
Lung Cancer
; 83(2): 224-30, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24388704
13.
A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer.
Acta Oncol
; 46(3): 374-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17450474
Resultados
1 -
13
de 13
1
Próxima >
>>